The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:

Notices

• Notice of Correction to Announcement Type for PAR-18-387 "Education and Health: New Frontiers (R01) Clinical Trial Optional"
  Office of the Director, NIH
• Request for Information (RFI): Input on Report from Council of Councils on Assessing the Safety of Relocating At-Risk Chimpanzees
  Office of the Director, NIH
• Early Registration Ends June 29 for Fall 2018 NIH Regional Seminar in San Francisco, CA
  Office of the Director, NIH
• Notice to Extend the Expiration Date for PAR-15-356 "Major Opportunities for Research in Epidemiology of Alzheimer's Disease and Cognitive Resilience (R01)"
  National Institute on Aging
• Notice to Extend the Expiration Date for PAR-15-358 "Capturing Complexity in the Molecular and Cellular Mechanisms Involved in the Etiology of Alzheimer's Disease (R01)"
  National Institute on Aging
• NIAID Policy for T32 and T35 Competing Renewal Application Submissions
  National Institute of Allergy and Infectious Diseases
• Notice of Availability of Administrative Supplements to Support Tool and Resource Development to Address Racial and Ethnic Disparities in Multiple Myeloma
  National Cancer Institute
• Notice of Availability of Administrative Supplements to NIBIB Grants: Technology Dissemination
  National Institute of Biomedical Imaging and Bioengineering
• Notice of Availability of Administrative Supplements to NIBIB Grants: Personalized Imaging Technologies
  National Institute of Biomedical Imaging and Bioengineering
• Notice of Availability of Administrative Supplements to NIBIB Grants: Machine Learning and Deep Learning Solutions
  National Institute of Biomedical Imaging and Bioengineering
• Notice of Change to Application Due Date in RFA-RM-18-006 "Limited Competition: Building Infrastructure Leading to Diversity (BUILD) Initiative Phase II (U54 - Clinical Trial Not Allowed)"
  National Institute of General Medical Sciences
• Phase-out and Termination of NIGMS Participation in the NIH MERIT (R37) Program
  National Institute of General Medical Sciences
• Notice of Frequently Asked Questions for RFA-HL-19-009 "Cardiothoracic Surgical Trials Network (CTSN) Linked Clinical Research Centers (UM1 Clinical Trial Not Allowed)"
  National Heart, Lung, and Blood Institute
• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network on Pain Research - Data Coordinating Center (U24 Clinical Trial Not Allowed)
  National Institute of Neurological Disorders and Stroke
• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trials Network on Pain Research Clinical Coordinating Center (U24 Clinical Trials not Allowed)
  National Institute of Neurological Disorders and Stroke
• Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Centers for the Clinical Trials Network on Pain Research (CTNPR) (U24 Clinical Trial Not Allowed)
  National Institute of Neurological Disorders and Stroke
• Notice of New Budget Limitation for PAR-16-331 Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
• Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional).
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute on Drug Abuse
  National Institute of Environmental Health Sciences
• Notice to update Application Types Allowed for PAR-18-464: Clinical and Translational Science Award (U54 Clinical Trial Optional)
  National Center for Advancing Translational Sciences

Requests for Applications

• Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)
  National Institute of Allergy and Infectious Diseases
  National Institute of Mental Health
   . 
• Immune Mechanisms at the Maternal-Fetal Interface (R01 Clinical Trial Optional)
  National Institute of Allergy and Infectious Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
   
• Gastrointestinal Mechanisms Contributing to HIV Pathogenesis (R01 Clinical Trial Not Allowed)
  National Institute of Diabetes and Digestive and Kidney Diseases
   
• Development of Novel Nonsteroidal Contraceptive Methods (R61/R33 - Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    
• Large Animal Testing Centers for Evaluation of Somatic Cell Genome Editing Tools (U42 - Clinical Trial Not Allowed)
  Office of Strategic Coordination (Common Fund)
    

Program Announcements

• Minor Use Minor Species Development of Drugs (R01)
  Food and Drug Administration
    
• NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
• NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
  National Center for Complementary and Integrative Health
  Office of Dietary Supplements
    
• The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
  National Cancer Institute
  National Eye Institute
    
• The Role of Epitranscriptomics in Development and Disease (R21 - Clinical Trial Not Allowed)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development 
    
• AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
• Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
  National Institute of Mental Health
   

Details, including application deadlines, when applicable, are available through the program links above.  To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html

Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Linda Meyer at linda-k-meyer@uiowa.edu, Paul Below at paul-below@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu